# Omacor and Cardiovascular Risk Factors in HIV Patients on HAART Treatment

> **NCT00296153** · PHASE4 · COMPLETED · sponsor: **Pronova BioPharma** · enrollment: 51 (actual)

## Conditions studied

- Human Immunodeficiency Virus
- Ischemic Heart Disease

## Interventions

- **DRUG:** Omega-3-acid ethyl esters 90

## Key facts

- **NCT ID:** NCT00296153
- **Lead sponsor:** Pronova BioPharma
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-02
- **Primary completion:** 2006-11
- **Final completion:** 2007-10
- **Target enrollment:** 51 (ACTUAL)
- **Last updated:** 2008-03-11

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00296153

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00296153, "Omacor and Cardiovascular Risk Factors in HIV Patients on HAART Treatment". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00296153. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*